Short answer
Praxis Precision Medicines, Inc. (PRAX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Fiscal results announced for quarter ended June 30, 2026.
Praxis Precision Medicines, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal results announced for quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1, containing detailed financial results and management commentary
- Investor focus: quarterly performance, cash position and clinical-program funding implications
Item 7.01 · Regulation FD Disclosure
- Updated corporate presentation for investor and analyst meetings as of August 6, 2026
- Presentation available on Praxis’s investor website and furnished as Exhibit 99.2
- Investor materials may contain updated strategy, pipeline, or clinical information requiring review
- Disclosure furnished under Regulation FD, limiting Section 18 Exchange Act liability for the presentation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Praxis Precision Medicines, Inc. 8-K filings
Get the next PRAX 8-K as it lands
Follow PRAX for push alerts, or ask the research agent what this filing means.